{"disease":{"id":"node-positive-breast-cancer","name":"node positive breast cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04842617","title":"Phase III Study ：SHR6390/Placebo Combined With Endocrine Therapy for the Adjuvant Treatment of Hormone Receptor Positive,Human Epidermal Receptor 2 Negative","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":5274,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT02927249","title":"Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":3021,"lead_sponsor_name":"Alliance for Clinical Trials in Oncology","has_results":true},{"nct_id":"NCT03413761","title":"Antioxidant Supplements, Genetics and Chemotherapy Outcomes","phase":"","overall_status":"COMPLETED","enrollment_count":1771,"lead_sponsor_name":"Roswell Park Cancer Institute","has_results":false},{"nct_id":"NCT04569747","title":"A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":393,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT06559540","title":"Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT04039893","title":"MUltimodal Targeted Axillary Surgery","phase":"NA","overall_status":"UNKNOWN","enrollment_count":160,"lead_sponsor_name":"Parc de Salut Mar","has_results":false},{"nct_id":"NCT02515110","title":"Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":137,"lead_sponsor_name":"Virginia Commonwealth University","has_results":false},{"nct_id":"NCT04826211","title":"Axillary Staging in Node Positive Breast Cancer Patients Receiving PST. SNB vs PET/MRI","phase":"NA","overall_status":"COMPLETED","enrollment_count":109,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT05676866","title":"Evaluation of Targeted Axillary Lymph Node Dissection in Node Positive Breast Cancer Patients Post Neo Adjuvant Therapy","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Assiut University","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}